ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN Astrazeneca Plc

11,988.00
-38.00 (-0.32%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -38.00 -0.32% 11,988.00 12,014.00 12,018.00 12,144.00 11,882.00 12,070.00 2,340,814 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.28 186.27B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,026p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,210.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £186.27 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.28.

Astrazeneca Share Discussion Threads

Showing 4626 to 4645 of 6150 messages
Chat Pages: Latest  186  185  184  183  182  181  180  179  178  177  176  175  Older
DateSubjectAuthorDiscuss
31/3/2021
09:58
Flip Flop


In a major about-face, Germany will halt the use of AstraZeneca's Covid vaccine for people younger than 60 today, just two months after recommending it only for younger cohorts, and later expanding it to all age groups. Germany’s move follows a report from the country’s vaccine agency of a rare brain blood clot in 31 people, nine of whom died.

With the exception of two people, all of the cases were women between the ages of 20 and 63. The development is a fresh blow for Astra’s vaccine -- and another threat to Europe’s inoculation campaign, which has already experienced delays, controversy and political battles.

Bloomberg

philanderer
30/3/2021
18:14
So why does that affect the share price when they are providing it for for free?Makes no bloody sense.
gateside
30/3/2021
18:13
AstraZeneca finished down 1.4% after the German state of Berlin said it is again suspending the use of the drugmaker's coronavirus vaccine for people under 60 due to reports of blood clots. In addition, Canada on Monday suspended use of AstraZeneca's Covid vaccine for those under 55 amid blood clot fears.

Alliance News

philanderer
30/3/2021
12:20
AstraZeneca vaccine - was it really worth it?


"It's appalling the way AstraZeneca has been treated. I wouldn't blame them if they were thoroughly fed up and decided to bow out of the covid vaccine business."

That was the view from one of the biggest institutional investors in the UK.

article:

philanderer
30/3/2021
00:23
ROB GILLIES
Mon, 29 March 2021, 6:45 pm
TORONTO (AP) — Canada on Monday suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots.

The National Advisory Committee on Immunization had recommended the pause for safety reasons and the Canadian provinces, which administer health in the country, announced the suspension Monday.

“There is substantial uncertainty about the benefit of providing AstraZeneca Covid-19 vaccines to adults under 55 given the potential risks,” said Dr. Shelley Deeks, vice chair of the National Advisory Committee on Immunization.

Deeks said the updated recommendations come amid new data from Europe that suggests the risk of blood clots is now potentially as high as one in 100,000, much higher than the one in one million risk believed before.

She said most of the patients in Europe who developed a rare blood clot after vaccination with AstraZeneca were women under age 55, and the fatality rate among those who develop clots is as high as 40%.

Dr. Joss Reimer of Manitoba’s Vaccine Implementation Task Force said despite the finding that there was no increase risk of blood clots overall related to AstraZeneca in Europe, a rare but very serious side effect has been seen primarily in young women in Europe.

Reimer said the rare type of blood clot typically happens between four and 20 days after getting the shot and the symptoms can mirror a stroke or a heart attack.

“While we still believe the benefits for all ages outweigh the risks I’m not comfortable with probably. I want to see more data coming out of Europe so I know exactly what this risk benefit analysis is,” Reimer said.

The AstraZeneca shot, which has been authorized in more than 70 countries, is a pillar of a U.N.-backed project known as COVAX that aims to get COVID-19 vaccines to poorer countries. It has also become a key tool in European countries’ efforts to boost their sluggish vaccine rollouts. That makes doubts about the shots especially worrying.

“This vaccine has had all the ups and downs. It looks like a roller coaster,” said Dr. Caroline Quach-Thanh, the chair of the National Advisory Committee on Immunization, when asked if the latest news will lead to further vaccine hesitancy.

Health Canada said it has not received any reports of blood clots in Canada, and the department’s chief medical adviser, Dr. Supriya Sharma, said she still believes the vaccine’s benefits outweigh the risks.

Last week, the department changed its label on the vaccine to warn about the rare risk of blood clots.

Only those 60 and above have received AstraZeneca in Ontario, Canada's most populous province.

“We have no concerns with those who have received it so far,” said Dr. David Williams, Ontario's chief medical officer.

Mark Mendelson, a 63-year-old Toronto man who has had heart surgery, said that he has no regrets about getting his first AstraZeneca dose two weeks ago and that he will get the second.

“Get what you can,” Mendelson said. “I had no ill effects at all from the AstraZeneca. I am in a better position than those who don’t have any vaccine at all. If you are betting person you would take those odds any day of the week. I’m quite prepared to roll the dice.”

Several European countries that had suspended using the vaccine over concerns it could cause blood clots have resumed administering it after the EU’s drug regulator said the vaccine was safe.

The vaccine is used widely in Britain, across the European continent and in other countries, but its rollout was troubled by inconsistent study reports about its effectiveness, and then more recently the scare about clots that had some countries temporarily pausing inoculations.

Canada is expected to receive 1.5 million doses of AstraZeneca from the U.S. this week.

“The messaging has been brutal overall. I am fearful it is toast. It shouldn't be," said Dr. Andrew Morris, a professor of infectious diseases at the University of Toronto and the medical director of the Antimicrobial Stewardship Program at Sinai-University Health Network.

Morris thinks those who are at a high risk for a bad COVID-19 outcome and over the age of 55 should get AstraZeneca if the other vaccines are not available to them, especially during a third wave of coronavirus infections.

Canadian regulators approved the Pfizer, Moderna, AstraZeneca and Johnson & Johnson vaccines. Canada has placed bigger bets on Pfizer and Moderna, ordering up to 76 million doses of Pfizer and up to 44 million of Moderna, compared with up to 20 million of AstraZeneca. It's not known when Canada will receive its first shipment of Johnson & Johnson.

Canada has lagged on vaccinating its population because it lacks the ability to manufacture the vaccine and has had to rely on the global supply chain for the lifesaving shots, like many other countries.

With no domestic supply, Prime Minister Justin Trudeau’s government bet on seven different vaccines manufactured elsewhere and secured advance purchase agreements — enough to get 10 doses for each of Canada’s 38 million people. While acquiring them has proven difficult, deliveries have ramped up this month. Canada expects to have more than 36.5 million doses by July and officials hope to get at least one dose into all adults who want one by the end of June.

The National Advisory Committee on Immunization earlier recommended a four-month delay between doses after data from the U.K. and Quebec showed a good level of protection offered by the first shot. The U.K. has instituted a similar delay.

johncasey
29/3/2021
15:30
BUPA : REFUSING to cover adverse reactions from an "experimental treatment" [Covid19 Vaccines
jimarilo
29/3/2021
14:35
AstraZeneca boss is returning to Europe from Australian home as he battles public relations crisis over firm's Covid vaccine
philanderer
29/3/2021
12:38
Ten stages of genocide
jimarilo
29/3/2021
12:04
Pure evil !

Anyone that thinks de-population is a theory, needs to sit down with a large drink and watch this. It has been happening for years....and by the same people





C19 Swab for brain cancer. "they're killing us!"

jimarilo
29/3/2021
11:24
Nice dividend paid into my EQI account this morning :-)
philanderer
29/3/2021
09:56
https://www.nasdaq.com/articles/6-words-from-pfizers-ceo-that-mean-trouble-for-moderna-and-biontech-2021-03-27
nick100
26/3/2021
19:07
Thanks AstraZeneca for being a better investment than GSK and for my AstraZeneca injection today :-)
gateside
26/3/2021
17:00
After all the bad mouthing AZ has taken over the past 3 months it amazes me that they are still pursuing a policy of selling their vaccine on a not-for-profit basis. If their contracts people have any nouse at all they should have put a market flex clause in their contracts and I would urge them to use it against any country or supra-national body that is making life difficult for them. A policy of espousing genuine humanitarian concern has been been totally undermined by too many tin pot politicians. Being the good guys hasn't been entirely successful here.
ygor705
26/3/2021
14:10
I felt a bit tired out for a few hrs, that was it.

The first dose is only 0.5 ml.

essentialinvestor
26/3/2021
13:54
Sky news breaking, R rate rises slightly. Testing and vaccines will be around for a long time.
montyhedge
26/3/2021
11:36
Scientists see if AstraZeneca vaccine can be used as a nasal spray
philanderer
26/3/2021
10:25
yes in July any vaccines will be at extra cost, if EU don't want it, most of the world want it. lol
onehanded
26/3/2021
10:23
Time to put the price up!
ianood
26/3/2021
08:51
The EU's attacking* of the AZ vaccine is really quite vile

(*while also demanding it)

stocktastic
26/3/2021
00:53
Very bullying behaviour!
growthpotential
Chat Pages: Latest  186  185  184  183  182  181  180  179  178  177  176  175  Older

Your Recent History

Delayed Upgrade Clock